Literature DB >> 19754872

Mechanisms of obesity and related pathology: linking immune responses to metabolic stress.

Katia P Karalis1, Panagiotis Giannogonas, Elisavet Kodela, Yassemi Koutmani, Manolis Zoumakis, Thalia Teli.   

Abstract

There is a tightly regulated interaction, which is well-conserved in evolution, between the metabolic and immune systems that is deranged in states of over- or under-nutrition. Obesity, an energy-rich condition, is characterized by the activation of an inflammatory process in metabolically active sites such as adipose tissue, liver and immune cells. The consequence of this response is a sharp increase in circulating levels of proinflammatory cytokines, adipokines and other inflammatory markers. Activation of the immune response in obesity is mediated by specific signaling pathways, with Jun N-terminal kinase and IkappaB kinase beta/nuclear factor kappa-light-chain-enhancer of activated B cells being the most well studied. It is known that the above events modify insulin signaling and result in the development of insulin resistance. The nutrient overload characterizing obesity is a metabolic stressor associated with intracellular organelle (e.g. the endoplasmic reticulum) stress. The exact characterization of the series of events and the mechanisms that integrate the inflammatory response with metabolic homeostasis at the cellular and systemic level is a very active research field. In this minireview, we discuss the signaling pathways and molecules associated with the development of obesity-induced inflammation, as well as the evidence that supports a critical role for the stress response in this process.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19754872     DOI: 10.1111/j.1742-4658.2009.07304.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  49 in total

Review 1.  Oxidative stress and inflammation interactions in human obesity.

Authors:  Isabel Bondia-Pons; Lisa Ryan; J Alfredo Martinez
Journal:  J Physiol Biochem       Date:  2012-02-17       Impact factor: 4.158

2.  Chemerin receptor blockade improves vascular function in diabetic obese mice via redox-sensitive and Akt-dependent pathways.

Authors:  Karla Bianca Neves; Aurelie Nguyen Dinh Cat; Rheure Alves-Lopes; Katie Yates Harvey; Rafael Menezes da Costa; Nubia Souza Lobato; Augusto Cesar Montezano; Ana Maria de Oliveira; Rhian M Touyz; Rita C Tostes
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-09-14       Impact factor: 4.733

3.  Transgenic expression of cholesterol 7alpha-hydroxylase in the liver prevents high-fat diet-induced obesity and insulin resistance in mice.

Authors:  Tiangang Li; Erika Owsley; Michelle Matozel; Peter Hsu; Colleen M Novak; John Y L Chiang
Journal:  Hepatology       Date:  2010-08       Impact factor: 17.425

Review 4.  Posttraumatic stress disorder: A metabolic disorder in disguise?

Authors:  Vasiliki Michopoulos; Aimee Vester; Gretchen Neigh
Journal:  Exp Neurol       Date:  2016-05-28       Impact factor: 5.330

5.  Weight gain and lung disease: the vagary of body mass index and the dilemma of the obese smoker.

Authors:  Benjamin T Suratt
Journal:  Am J Respir Crit Care Med       Date:  2014-02-01       Impact factor: 21.405

Review 6.  Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress.

Authors:  George W Booz
Journal:  Free Radic Biol Med       Date:  2011-01-14       Impact factor: 7.376

7.  Computed tomography attenuation and patient characteristics as predictors of complications after pancreaticoduodenectomy.

Authors:  John C McAuliffe; Karen Parks; Prakash Kumar; Sandre F McNeal; Desiree E Morgan; John D Christein
Journal:  HPB (Oxford)       Date:  2013-01-10       Impact factor: 3.647

Review 8.  Role of heme oxygenase in inflammation, insulin-signalling, diabetes and obesity.

Authors:  Joseph Fomusi Ndisang
Journal:  Mediators Inflamm       Date:  2010-05-18       Impact factor: 4.711

9.  Pleural fluid analysis of lung cancer vs benign inflammatory disease patients.

Authors:  R Kremer; L A Best; D Savulescu; M Gavish; R M Nagler
Journal:  Br J Cancer       Date:  2010-03-09       Impact factor: 7.640

Review 10.  Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells.

Authors:  Giovanni Anfossi; Isabella Russo; Gabriella Doronzo; Alice Pomero; Mariella Trovati
Journal:  Mediators Inflamm       Date:  2010-06-28       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.